Intrathecal IgM synthesis as a biomarker of disease activity in algerian multiple sclerosis patients

被引：0
|
作者：
Hadjout, Tamazouzt [1 ]
Kechoud, Sarah [1 ]
Megherbi, Lilia [2 ]
Marir, Sofia [1 ]
Balaouane, Hassina [1 ]
Attal, Elias [2 ]
Daoudi, Smail [2 ]
Attal, Nabila [1 ]
机构：
[1] Inst Pasteur Algeria, Dept Immunol, Algiers, Algeria
[2] Tizi Ouzou Hosp, Dept Neurol, Tizi Ouzou, Algeria
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2021年 / 51卷
关键词：
Antibody; biomarkers; multiple sclerosis; neuroimmunology;
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P-0988
引用
收藏
页码：375 / 375
页数：1
相关论文
共 50 条
  • [21] C3c intrathecal synthesis evaluation in patients with multiple sclerosis
    Padilla-Docal, Barbara
    Dorta-Contreras, Alberto J.
    Fundora-Hernandez, Hermes
    Noris-Garcia, Elena
    Bu-Coifiu-Fanego, Raisa
    Gonzalez-Hernandez, Marlen
    Rodriguez-Rey, Alexis
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2007, 65 (3B) : 800 - 802
  • [22] Cytokines and Intrathecal Synthesis of Oligoclonal IgG in Viliuisk Encephalomyelitis and Multiple Sclerosis Patients
    Sivtseva, T. M.
    Chemezova, R., I
    Vladimirtsev, V. A.
    Nikitina, R. S.
    Danilova, A. P.
    Popova, T. E.
    Okoneshnikova, L. T.
    Osakovsky, V. L.
    YAKUT MEDICAL JOURNAL, 2011, (04): : 38 - 44
  • [23] IgM to phosphatidylcholine in multiple sclerosis patients: from the diagnosis to the treatment
    Sanchez-Vera, Isabel
    Escudero, Esther
    Munoz, Ursula
    Sadaba, Maria C.
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2023, 16
  • [24] Movement disorders in a cohort of Algerian patients with multiple sclerosis
    Hatteb, S. A.
    Daoudi, S.
    REVUE NEUROLOGIQUE, 2018, 174 (03) : 167 - 172
  • [25] Systemic complement profiling in multiple sclerosis as a biomarker of disease state
    Ingram, G.
    Hakobyan, S.
    Hirst, C. L.
    Harris, C. L.
    Loveless, S.
    Mitchell, J. P.
    Pickersgill, T. P.
    Robertson, N. P.
    Morgan, B. P.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (10) : 1401 - 1411
  • [26] Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis
    Liuzzi, GM
    Trojano, M
    Fanelli, M
    Avolio, C
    Fasano, A
    Livrea, P
    Riccio, P
    MULTIPLE SCLEROSIS, 2002, 8 (03): : 222 - 228
  • [27] Is it cost-effective to request IgM oligoclonal bands against lipids in daily practice as a biomarker for poor prognosis in multiple sclerosis?
    Garcia, Sara Ribes
    Castillo-Villalba, Jessica
    Rubio, Raquel Gasque
    Bosca, Sara Carratala
    Cubas-Nunez, Laura
    Alcala, Carmen
    Perez-Miralles, Francisco Carlos
    Bonaventura, Casanova Estruch
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 79
  • [28] Intrathecal baclofen therapy: Challenges in patients with multiple sclerosis
    Ridley, B
    REHABILITATION NURSING, 2006, 31 (04) : 158 - 164
  • [29] Intrathecal baclofen for treatment of spasticity of multiple sclerosis patients
    Ben Smail, D
    Peskine, A
    Roche, N
    Mailhan, L
    Thiébaut, JB
    Bussel, B
    MULTIPLE SCLEROSIS, 2006, 12 (01): : 101 - 103
  • [30] Assessing the presence of oligoclonal IgM bands as a prognostic biomarker of cognitive decline in the early stages of multiple sclerosis
    Coll-Martinez, Claudia
    Quintana, Ester
    Salavedra-Pont, Judit
    Buxo, Maria
    Gonzalez-del-Rio, Marina
    Gomez, Immaculada
    Munoz-San Martin, Maria
    Villar, Luisa Maria
    Alvarez-Bravo, Gary
    Robles-Cedeno, Rene
    Ramio-Torrenta, Lluis
    Gich, Jordi
    BRAIN AND BEHAVIOR, 2021, 11 (12):
12345